Earnings Outlook For Seres Therapeutics
Portfolio Pulse from Benzinga Insights
Seres Therapeutics (NASDAQ:MCRB) is set to release its latest quarterly earnings report on November 2, 2023. Analysts estimate an earnings per share (EPS) of $-0.50. The company's past performance shows a trend of missing EPS estimates and subsequent share price drops. The stock is currently trading at $1.53, down 85.04% over the last 52-week period.
November 01, 2023 | 7:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Seres Therapeutics is expected to report an EPS of $-0.50 in its upcoming earnings release. The company's history of missing EPS estimates and subsequent share price drops could impact investor sentiment.
Seres Therapeutics has a history of missing EPS estimates, which has previously led to share price drops. Given this trend and the negative analyst estimate for the upcoming earnings, the stock price is likely to be negatively impacted in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100